These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6759010)

  • 1. [Action of calcium 2,2'-disulfohexanoate on the course of acute viral hepatitis: double-blind study].
    Calonghi G; Sueri L
    Clin Ter; 1982 Nov; 103(3):273-82. PubMed ID: 6759010
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I; Schmidt FW; Müller R; Ranft U; Wildhirt E; Holzer E; Wallnöfer H; Korb G
    Dtsch Med Wochenschr; 1980 Mar; 105(10):330-2. PubMed ID: 6153953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A double-blind clinical study of the effect of a new molecule (+)-cyanidanol-3 on the course of the clinical symptoms and biological parameters of viral hepatitis].
    Cachin M; Dupuy R; Boutelier D; Levy C
    Minerva Dietol Gastroenterol; 1977; 23(4):307-12. PubMed ID: 349422
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrahepatic cholestasis in acute viral hepatitis: a double-blind trial with dihydroxydibutylether in comparison with placebo.
    Marchettini G; Corsini P; Massimini G
    Drugs Exp Clin Res; 1987; 13(1):51-6. PubMed ID: 3297594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium-2,2'-disulfohexanoate in the treatment of liver diseases: study of a series of 15 patients].
    Piludu G; Perpignano G
    Clin Ter; 1981 May; 97(4):377-82. PubMed ID: 7249568
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ribavirin in the treatment of acute viral hepatitis].
    de Mendonça JS; Amato Neto V; Pasternak J; Rodrigues EA; Sado K; de Andrade JG; Zanini LA
    Rev Paul Med; 1982; 99(3):4-6. PubMed ID: 6760344
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double blind studies in acute viral hepatitis].
    Jesdinsky HJ
    Dtsch Med Wochenschr; 1980 Mar; 105(10):315-6. PubMed ID: 7363761
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic study of hexanoic acid in tympanoplasties].
    Charachon R; Junien-Lavillauroy PC; Serero C; Accoyer B
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 May; 24(5):401-2. PubMed ID: 126284
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of acute and chronic liver diseases with calcium-2,2'-disulfohexanoate].
    Ravetta A
    Clin Ter; 1979 Aug; 90(4):357-68. PubMed ID: 262631
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in some blood chemical parameters in patients with chronic liver diseases treated with calcium-2,2'-disulfohexanoate].
    Turpini R; Scotti A; Brusoni V; Perego M
    Clin Ter; 1980 Jun; 93(6):689-94. PubMed ID: 7428323
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of acute viral hepatitis with (+)-cyanidanol-3].
    Pelloni S; Berthet P; Blum AL; Doelle W; Goebell H; Kortüm K; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1859-61. PubMed ID: 337476
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the cicatrizant action of N-acetyl-amino-6-hexanoic acid. Further clinical trials].
    Bassi R; Schiesari G
    G Ital Dermatol Minerva Dermatol; 1971 May; 46(5):224-30. PubMed ID: 5109150
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of calcium 2,2'-disulfohexanoate in chronic hepatopathies].
    Ortolan A; Martin A; Pieropan G
    Minerva Dietol Gastroenterol; 1978; 24(1):7-11. PubMed ID: 740272
    [No Abstract]   [Full Text] [Related]  

  • 14. [The therapeutic activity of stepronin in viral hepatitis].
    Bosio G; Bramato C; Salassa B; Andreoni G; Magliocca R
    Minerva Med; 1982 Oct; 73(41):2897-904. PubMed ID: 6752758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribavirin trial in cases of infective hepatitis.
    Kumta NB; Antani DN
    Indian Pediatr; 1983 Feb; 20(2):99-103. PubMed ID: 6345384
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
    Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uridine diphosphate glucose in acute viral hepatitis].
    Crispo C; Perruna F; Di Nicuolo G; Rosiello A
    Minerva Med; 1982 Feb; 73(5):187-90. PubMed ID: 7038553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind clinical trial of Arogya-wardhani--an ayurvedic drug--in acute viral hepatitis.
    Antarkar DS; Vaidya AB; Doshi JC; Athavale AV; Vinchoo KS; Natekar MR; Tathed PS; Ramesh V; Kale N
    Indian J Med Res; 1980 Oct; 72():588-93. PubMed ID: 7014428
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of trypsin on the course of viral hepatitis and blood levels of various biochemical indicators].
    Luk'ianov NF
    Vrach Delo; 1981 Mar; (3):122-4. PubMed ID: 7293131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.